A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
Harris PE, Brasel T, Massey C, Herst CV, Burkholz S, Lloyd P, Blankenberg T, Bey TM, Carback R, Hodge T, Ciotlos S, Wang L, Comer JE, Rubsamen RM.
Harris PE, et al. Among authors: rubsamen rm.
Vaccines (Basel). 2021 May 18;9(5):520. doi: 10.3390/vaccines9050520.
Vaccines (Basel). 2021.
PMID: 34070152
Free PMC article.